Related Articles
Reactive cutaneous capillary endothelial proliferations of the eyelids induced by camrelizumab: A case report
Efficacy and safety of camrelizumab (a PD‑1 inhibitor) combined with chemotherapy as a neoadjuvant regimen in patients with locally advanced non‑small cell lung cancer
PD‑1/PD‑L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)
Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot study
Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non‑Hodgkin's lymphoma: A prospective study of 46 cases